Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Using treatment response to subtype schizophrenia: proposal for a new paradigm in classification.

Literature DB >> 24045038

Using treatment response to subtype schizophrenia: proposal for a new paradigm in classification.

Saeed Farooq¹, Ofer Agid, George Foussias, Gary Remington.

Abstract

Entities: Disease

Mesh：

Year: 2013 PMID： 24045038 PMCID： PMC3796094 DOI： 10.1093/schbul/sbt137

Source DB: PubMed Journal: Schizophr Bull ISSN： 0586-7614 Impact factor: 9.306

× No keyword cloud information.

35 in total

Review 1. Understanding antipsychotic "atypicality": a clinical and pharmacological moving target.

Authors: Gary Remington
Journal: J Psychiatry Neurosci Date: 2003-07 Impact factor: 6.186

2. Medication-adherent first-episode psychosis patients also relapse: why?

Authors: Emmanuelle Levy; Nicole Pawliuk; Ridha Joober; Sherezad Abadi; Ashok Malla
Journal: Can J Psychiatry Date: 2012-02 Impact factor: 4.356

3. An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis.

Authors: Ofer Agid; Tamara Arenovich; Gautam Sajeev; Robert B Zipursky; Shitij Kapur; George Foussias; Gary Remington
Journal: J Clin Psychiatry Date: 2011-03-08 Impact factor: 4.384

4. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.

Authors: D G Robinson; M G Woerner; J M Alvir; S Geisler; A Koreen; B Sheitman; M Chakos; D Mayerhoff; R Bilder; R Goldman; J A Lieberman
Journal: Am J Psychiatry Date: 1999-04 Impact factor: 18.112

Review 5. Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.

Authors: S Kapur; G Remington
Journal: Biol Psychiatry Date: 2001-12-01 Impact factor: 13.382

6. Staging of disease. A case-mix measurement.

Authors: J S Gonnella; M C Hornbrook; D Z Louis
Journal: JAMA Date: 1984-02-03 Impact factor: 56.272

7. Identification of clinically meaningful relationships among cognition, functionality, and symptoms in subjects with schizophrenia or schizoaffective disorder.

Authors: Gahan Pandina; Robert Bilder; Ibrahim Turkoz; Larry Alphs
Journal: Schizophr Res Date: 2012-12-28 Impact factor: 4.939

8. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors: J Kane; G Honigfeld; J Singer; H Meltzer
Journal: Arch Gen Psychiatry Date: 1988-09

9. Clozapine: dangerous orphan or neglected friend?

Authors: Saeed Farooq; Mark Taylor
Journal: Br J Psychiatry Date: 2011-04 Impact factor: 9.319

Review 10. Emerging drugs for schizophrenia.

Authors: Ofer Agid; Shitij Kapur; Gary Remington
Journal: Expert Opin Emerg Drugs Date: 2008-09 Impact factor: 4.191

24 in total

1. Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study.

Authors: Parita Shah; Yusuke Iwata; Eric E Brown; Julia Kim; Marcos Sanches; Hiroyoshi Takeuchi; Shinichiro Nakajima; Margaret Hahn; Gary Remington; Philip Gerretsen; Ariel Graff-Guerrero
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2019-08-19 Impact factor: 5.270

Review 2. Guidelines for the Pharmacotherapy of Schizophrenia in Adults.

Authors: Gary Remington; Donald Addington; William Honer; Zahinoor Ismail; Thomas Raedler; Michael Teehan
Journal: Can J Psychiatry Date: 2017-07-13 Impact factor: 4.356

Review 3. Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia.

Authors: Shinichiro Nakajima; Hiroyoshi Takeuchi; Eric Plitman; Gagan Fervaha; Philip Gerretsen; Fernando Caravaggio; Jun Ku Chung; Yusuke Iwata; Gary Remington; Ariel Graff-Guerrero
Journal: Schizophr Res Date: 2015-02-13 Impact factor: 4.939

4. Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms.

Authors: Jimmy Lee; Hiroyoshi Takeuchi; Gagan Fervaha; Gwen Li Sin; George Foussias; Ofer Agid; Saeed Farooq; Gary Remington
Journal: Can J Psychiatry Date: 2015-11 Impact factor: 4.356

5. Response trajectories to clozapine in a secondary analysis of pivotal trials support using treatment response to subtype schizophrenia.

Authors: William G Honer; Andrea A Jones; Allen E Thornton; Alasdair M Barr; Ric M Procyshyn; Fidel Vila-Rodriguez
Journal: Can J Psychiatry Date: 2015-03 Impact factor: 4.356